Do high-risk features support the use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study


ARTAÇ M., Turha N. S. , Kocer M., KARABULUT B., Bozcuk H., Yalcin S., ...Daha Fazla

TUMORI J, cilt.100, ss.143-148, 2014 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 100 Konu: 2
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1700/1491.16397
  • Dergi Adı: TUMORI J
  • Sayfa Sayıları: ss.143-148

Özet

Background. A high-risk group of patients with stage II colon cancer has been identified by the results of studies in Western populations. The aim of this study was to investigate the prognostic factors of adjuvant chemotherapy in Turkish patients with stage II colon cancer.